BioSpace News Archive

Exasol, the high-performance analytics database, announced that Pharmascience Inc., a leading Canadian manufacturer of prescription, over-the-counter, and behind-the-counter generic pharmaceuticals, has selected Exasol to give end-users faster, more efficient access to data.

Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announces financial results for its fiscal third quarter ending December 31, 2020 and provides a corporate update.

Enlivex Therapeutics Ltd., (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company targeting diseased macrophages in patients with sepsis, COVID-19 and solid tumors, today announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,927,343 covering Allocetra TM , the company’s immunotherapy product candidate. The new patent is expected to provide added intellectual property protec

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that animal testing has commenced with two proprietary compounds that have shown potency in in vitro studies.

New research found that weight loss after diagnosis was associated with worse outcomes for HER2-positive early breast cancer patients

AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today announced the execution of a Letter of Intent with Silo Pharma Inc. (“Silo”) to grant to AIkido a worldwide, exclusive sublicense for use of peptide therapy, combined with psilocybin, in the therapeutic treatment of neuroinflammatory disease in cancer patients.

RLS-0071 is a dual targeting anti-inflammatory peptide that inhibits complement and inflammatory processes such as neutrophil activation and NETosis RLS-0071 is in development for treatment of Acute Lung Injury due to COVID-19 Pneumonia